News

Hikma licenses Vibativ from Theravance for MENA region

02-07-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) says it has signed an exclusive commercialization…

Antibiotics and Infectious diseasesHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldTheravanceVibativ

Hikma in-licenses inhaled insulin for MENA; Advaxis and FusionVax Asia deal

23-04-2013

Jordan-based Hikma Pharmaceuticals (LSE: HIK) has signed a licensing and distribution agreement with…

AdvaxisADXS-HPVAsia-PacificDance 01Dance BiopharmDiabetesFusionVaxHikma PharmaceuticalsImmunologicalsLicensingOncologyPharmaceuticalRest of the World

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle

19-03-2013

UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Vifor Pharma ties up with Hikma for Ferinject in Middle East and North Africa

17-08-2011

Switzerland-based Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), has entered into a collaboration…

FerinjectFinancialGalenicaHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldVifor Pharma

Hikma expands its manufacturing capabilities in Algeria taking full control of JV; signs biosimilars deal with CellTrion

13-04-2010

Jordanian-owned Hikma Pharmaceuticals says that its wholly-owned subsidiary, Arab Pharmaceutical Manufacturing…

BiotechnologyCellTrionGenericsHikma PharmaceuticalsLicensingMergers & AcquisitionsPharmaceuticalRest of the World

Back to top